Zunsemetinib

Item number	Size	Delivery time	Price
TGM-T39126-1mg	1 mg	7 - 10 business days*	281.00€
TGM-T39126-5mg	5 mg	7 - 10 business days*	687.00€
TGM-T39126-10mg	10 mg	7 - 10 business days*	1,181.00€
TGM-T39126-25mg	25 mg	7 - 10 business days*	1,761.00€
TGM-T39126-50mg	50 mg	7 - 10 business days*	2,372.00€
TGM-T39126-100mg	100 mg	7 - 10 business days*	3,185.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38alpha... more

Close menu

Product information "Zunsemetinib"

Description: Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38alpha mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis. Target: MAPK. Smiles: Cc1cnc(cc1-n1c(C)cc(OCc2ncc(F)cc2F)c(Cl)c1=O)-c1ccnc(n1)C(C)(C)O. References: Zunsemetinib (ATI-450) - Investigational oral MK2 pathway inhibitor

Keywords:	CDD-450, ATI-450
Supplier:	TargetMol
Supplier-Nr:	T39126

Properties

Application:	Targets mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1] (MAPKAPK2)
MW:	513.92 D
Formula:	C25H22ClF2N5O3
Format:	32160405